Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
Depreciation & Amortization
Adaptive Biotechnologies Corp
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Depreciation & Amortization
$22m
|
CAGR 3-Years
34%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Depreciation & Amortization
$3.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
13%
|
|
Danaher Corp
NYSE:DHR
|
Depreciation & Amortization
$2.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Depreciation & Amortization
$122.1m
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
Agilent Technologies Inc
NYSE:A
|
Depreciation & Amortization
$266m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Depreciation & Amortization
$1.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
26%
|
See Also
What is Adaptive Biotechnologies Corp's Depreciation & Amortization?
Depreciation & Amortization
22m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Depreciation & Amortization amounts to 22m USD.
What is Adaptive Biotechnologies Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
28%
Over the last year, the Depreciation & Amortization growth was 3%. The average annual Depreciation & Amortization growth rates for Adaptive Biotechnologies Corp have been 34% over the past three years , 28% over the past five years .